187 related articles for article (PubMed ID: 9635833)
1. Increased plasminogen binding is associated with metastatic breast cancer cells: differential expression of plasminogen binding proteins.
Ranson M; Andronicos NM; O'Mullane MJ; Baker MS
Br J Cancer; 1998 May; 77(10):1586-97. PubMed ID: 9635833
[TBL] [Abstract][Full Text] [Related]
2. The topology of plasminogen binding and activation on the surface of human breast cancer cells.
Andronicos NM; Ranson M
Br J Cancer; 2001 Sep; 85(6):909-16. PubMed ID: 11556845
[TBL] [Abstract][Full Text] [Related]
3. Plasminogen binding and activation at the breast cancer cell surface: the integral role of urokinase activity.
Stillfried GE; Saunders DN; Ranson M
Breast Cancer Res; 2007; 9(1):R14. PubMed ID: 17257442
[TBL] [Abstract][Full Text] [Related]
4. The plasminogen system and cell surfaces: evidence for plasminogen and urokinase receptors on the same cell type.
Plow EF; Freaney DE; Plescia J; Miles LA
J Cell Biol; 1986 Dec; 103(6 Pt 1):2411-20. PubMed ID: 3023400
[TBL] [Abstract][Full Text] [Related]
5. Tumour cell thrombospondin-1 regulates tumour cell adhesion and invasion through the urokinase plasminogen activator receptor.
Albo D; Rothman VL; Roberts DD; Tuszynski GP
Br J Cancer; 2000 Aug; 83(3):298-306. PubMed ID: 10917542
[TBL] [Abstract][Full Text] [Related]
6. Urokinase and the urokinase receptor: association with in vitro invasiveness of human bladder cancer cell lines.
Hudson MA; McReynolds LM
J Natl Cancer Inst; 1997 May; 89(10):709-17. PubMed ID: 9168186
[TBL] [Abstract][Full Text] [Related]
7. Role of urokinase plasminogen activator receptor in thrombospondin 1-mediated tumor cell invasion.
Albo D; Berger DH; Rothman VL; Tuszynski GP
J Surg Res; 1999 Apr; 82(2):331-8. PubMed ID: 10090848
[TBL] [Abstract][Full Text] [Related]
8. THP-1 macrophage membrane-bound plasmin activity is up-regulated by transforming growth factor-beta 1 via increased expression of urokinase and the urokinase receptor.
Falcone DJ; McCaffrey TA; Mathew J; McAdam K; Borth W
J Cell Physiol; 1995 Aug; 164(2):334-43. PubMed ID: 7622580
[TBL] [Abstract][Full Text] [Related]
9. Cell-surface cytokeratin 8 is the major plasminogen receptor on breast cancer cells and is required for the accelerated activation of cell-associated plasminogen by tissue-type plasminogen activator.
Hembrough TA; Li L; Gonias SL
J Biol Chem; 1996 Oct; 271(41):25684-91. PubMed ID: 8810346
[TBL] [Abstract][Full Text] [Related]
10. The urokinase receptor: involvement in cell surface proteolysis and cancer invasion.
Ellis V; Pyke C; Eriksen J; Solberg H; Danø K
Ann N Y Acad Sci; 1992 Dec; 667():13-31. PubMed ID: 1339241
[No Abstract] [Full Text] [Related]
11. Regulation of macrophage receptor-bound plasmin by autoproteolysis.
Falcone DJ; Borth W; McCaffrey TA; Mathew J; McAdam K
J Biol Chem; 1994 Dec; 269(51):32660-6. PubMed ID: 7528219
[TBL] [Abstract][Full Text] [Related]
12. Assembly of urokinase receptor-mediated plasminogen activation complexes involves direct, non-active-site interactions between urokinase and plasminogen.
Ellis V; Whawell SA; Werner F; Deadman JJ
Biochemistry; 1999 Jan; 38(2):651-9. PubMed ID: 9888805
[TBL] [Abstract][Full Text] [Related]
13. Expression and localization of elements of the plasminogen activation system in benign breast disease and breast cancers.
Jankun J; Merrick HW; Goldblatt PJ
J Cell Biochem; 1993 Oct; 53(2):135-44. PubMed ID: 8227186
[TBL] [Abstract][Full Text] [Related]
14. Receptor mediated binding of the fibrinolytic components, plasminogen and urokinase, to peripheral blood cells.
Miles LA; Plow EF
Thromb Haemost; 1987 Oct; 58(3):936-42. PubMed ID: 2829380
[TBL] [Abstract][Full Text] [Related]
15. Receptor-mediated regulation of plasminogen activator function: plasminogen activation by two directly membrane-anchored forms of urokinase.
Vines DJ; Lee SW; Dichek DA; Ellis V
J Pept Sci; 2000 Sep; 6(9):432-9. PubMed ID: 11016879
[TBL] [Abstract][Full Text] [Related]
16. Specific inhibition of the activity of the urokinase receptor-mediated cell-surface plasminogen activation system by suramin.
Ellis V; Danø K
Biochem J; 1993 Dec; 296 ( Pt 2)(Pt 2):505-10. PubMed ID: 8257443
[TBL] [Abstract][Full Text] [Related]
17. Stimulation of human breast carcinoma cell invasiveness and urokinase plasminogen activator activity by glucose deprivation.
Belkacemi L; Lam E; Caldwell JD; Siemens DR; Graham CH
Exp Cell Res; 2006 Jun; 312(10):1685-92. PubMed ID: 16564525
[TBL] [Abstract][Full Text] [Related]
18. Angiogenesis-associated protein annexin II in breast cancer: selective expression in invasive breast cancer and contribution to tumor invasion and progression.
Sharma MR; Koltowski L; Ownbey RT; Tuszynski GP; Sharma MC
Exp Mol Pathol; 2006 Oct; 81(2):146-56. PubMed ID: 16643892
[TBL] [Abstract][Full Text] [Related]
19. Elevated urokinase-specific surface receptor expression is maintained through its interaction with urokinase plasminogen activator.
Mahanivong C; Yu J; Huang S
Mol Carcinog; 2007 Mar; 46(3):165-75. PubMed ID: 17186542
[TBL] [Abstract][Full Text] [Related]
20. Reduction of breast carcinoma tumor growth and lung colonization by overexpression of the soluble urokinase-type plasminogen activator receptor (CD87).
Krüger A; Soeltl R; Lutz V; Wilhelm OG; Magdolen V; Rojo EE; Hantzopoulos PA; Graeff H; Gänsbacher B; Schmitt M
Cancer Gene Ther; 2000 Feb; 7(2):292-9. PubMed ID: 10770639
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
